期刊文献+

托特罗定联合坦索罗辛治疗输尿管结石临床价值 被引量:5

Clinical value of tolterodine combined with tamsulosin on the treatment of ureteral calculi
下载PDF
导出
摘要 目的探讨托特罗定联合坦索罗辛治疗输尿管结石的临床效果和安全性。方法将解放军11医院自2012年2月至2014年5月收治的219例输尿管结石患者,按随机数字表法分为两组。其中,观察组110例患者,使用托特罗定联合坦索罗辛进行治疗;对照组109例患者,仅使用坦索罗辛治疗。治疗4周后,比较两组患者的结石排石率、结石排出时间、肾绞痛发生率及疼痛视觉模拟评分(VAS)等指标并记录不良反应发生情况。结果观察组患者的总结石排石率为76.4%(84/110),对照组的结石排除率为57.8%(63/109),两组比较,差异有显著统计学意义(P<0.01)。观察组平均结石排出时间和VAS评分均低于对照组,差异有显著统计学意义(P<0.01)。观察组输尿管下段结石组肾绞痛发生率为13.2%(9/68),对照组为27.9%(17/61),两组比较,差异有统计学意义(P<0.05)。观察组的不良反应发生率为8.2%(9/110),对照组为5.5%(6/109),两组比较,差异无统计学意义(P>0.05),两组均无严重不良反应发生。结论托特罗定联合坦索罗辛治疗输尿管结石安全有效,尤其可提高输尿管中下段结石的清除率,缩短结石排出时间,减轻疼痛。 Objective To investigate tolterodine combined with tamsulosin clinical effect and safety in the treatment of ureteral calculi. Methods Totally 219 cases with ureteral calculi from February 2012 to May 2014 in our hospital were randomly divided into the observation group and the control group. In observation group,110 cases who had undergone tolterodine combined with tamsulosin. In control group,109 cases who had undergone tamsulosin only. All the cases were treated and accepted follow-ups for 4 weeks. Patients of both groups were compared in success rate of stone clearance,time of calculi expulsion,incidence of renal colic episodes and visual analogue scale pain score. Adverse effects were recorded. Results The rate of stone clearance were 76. 4%(84 /110) for the observation group and 57. 8%(63 /109) for the control group( P〈 0. 01). The time for calculi expulsion and visual analogue scale pain score had significantly decreased in patients of observation group compared with the ones of control group. The rate of renal colic episodes of lower ureteral calculi were 13. 2%(9 /68) for the observation group and 27. 9%(17 /61) for the control group( P〈 0. 05). The total incidences of adverse events in observation group and control group were 8. 2%(9 /110) and 5. 5%(6 /109),respectively. And there was no severe adverse event happened in both groups. Conclusion Tolterodine combined with tamsulosin is safe and efficient in the treatment of ureteral calculi. Tolterodine combined with tamsulosin may improve the stone clearance,shorten the mean time for calculi expulsion,decrease the visual analogue scale pain score in patients with middle and lower ureteral calculi.
出处 《临床军医杂志》 CAS 2016年第2期124-127,共4页 Clinical Journal of Medical Officers
关键词 输尿管结石 托特罗定 坦索罗辛 Ureteral calculi Tolterodine Tamsulosin
  • 相关文献

参考文献13

  • 1褚庆明,杨晓峰,付向阳,王锦锰,巴莹.M-受体阻断剂联合α-受体阻滞剂治疗中下段输尿管结石疗效观察[J].山东医药,2011,51(13):89-90. 被引量:7
  • 2AndersonJK,KabalinJN,CadedduJA.腹膜后腔、肾上腺、肾及输尿管的解剖(郭应禄,周立群译)[M].第9版.坎贝尔-沃尔什泌尿外科学.北京:北京大学医学出版社,2009:3-38.
  • 3Singh SK, Pawar DS, Griwan MS, et al. Role of tamsulosin in clearance of upper ureteral calculi after extracorporeal shock wave lithotripsy : a randomized controlled trial[ J ]. J Urol, 2011,8 ( 1 ) : 14-20.
  • 4Morse RM, Resniek MI. Ureteral calculi: natural history and treat- ment in an era of advanced technology [ J ]. J Urol, 1991,145 (2) : 263-265.
  • 5Parsons JK, Hergan LA, Sakamoto K, et al. Efficacy of alpha- blockers for the treatment of ureteral stones [ J ]. J Urol, 2007, 177 (3) :983-987.
  • 6Seitz C, Fajkovic H, Waldert M, et al. Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success [ J ] ? Eur Urol, 2006,49 ( 2 ) :378-383.
  • 7谢辉,廖新惠,周坤,陈洪德,杨宇,杨亦荣.α_1肾上腺素受体亚型在正常输尿管中下段的分布及其临床意义[J].临床泌尿外科杂志,2011,26(4):254-257. 被引量:6
  • 8Nakada SY, Coyle TL, Ankem MK, et al. Doxazosin relaxes ureter- al smooth muscle and inhibits epinephrine-induced ureteral con- tractility in vitro[ J]. Urology,2007,70(4) :817-821.
  • 9Bhagat SK, Chaeko NK, Kekre NS, et al. Is there a role for tamsu- losin in shock wave lithotripsy for renal and ureteral calculi [ J] .9 J Urol,2007,177 (6) :2185-2188.
  • 10师磊,杨阳,易强,袁璞,杨小明,宋东奎.坦索罗辛治疗输尿管远端结石的疗效观察[J].临床泌尿外科杂志,2012,27(6):472-473. 被引量:11

二级参考文献50

  • 1吕家驹,尉立京,张辉,丁森泰,丁克家.坦索罗辛和硝苯地平在输尿管下段结石辅助排石中作用的比较[J].中华泌尿外科杂志,2006,27(9):612-614. 被引量:88
  • 2熊玮,王坤杰,王莉,王佳,魏强,李虹.坦索罗辛用于输尿管结石排石治疗随机对照试验的Meta分析[J].中国循证医学杂志,2007,7(7):506-515. 被引量:22
  • 3Sigala S,dellabella M,Milanese G,et al.Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter[J].Neurourol Urodyn,2005,24(2):142-148.
  • 4Morse RM,Resnick MI.Ureteral calculi:natural history and treatment in an era of advanced technology[J].J Urol,1991,145:263-265.
  • 5Yilmaz E,Batislam E,Basar MM,et al.The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones[J].J Urol,2005,173(6):2010-2012.
  • 6Itoh Y, Kojima Y, Yasui T, et al. Examination of al- pha 1 adrenoceptor subtypes in the human ureter[J]. Int J Urol,2007,14(8):749-753.
  • 7ASigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter[J]. Neurourol Urodyn, 2005, 24 (2):142-148.
  • 8APark H K,Choi E Y,Jeong B C,et al. Localizations and expressions of alpha-1A, alpha-1B and alpha 1D adrenoceptors in human ureter[J]. Urol Res, 2007,35 (6).:325-329.
  • 9AYilmaz E,Batislam E,Basar M M,et al. The com- parison and efficacy of 3 different alphal adrenergic blockers for distal ureteral stones[J]. J Urol, 2005, 173(6) :2010-2012.
  • 10AAgrawal M, Gupta M, Gupta A, et al. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones [J]. Urology,2009,73(4) :706-709.

共引文献50

同被引文献50

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部